Recap: Fusion Pharmaceuticals Q4 Earnings - Fusion Pharmaceuticals (NASDAQ:FUSN)

Fusion Pharmaceuticals FUSN reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Fusion Pharmaceuticals missed estimated earnings by -15.0%, reporting an EPS of $-0.39 versus an estimate of $-0.34.

Revenue was down $140 thousand from the same period last year.

Last quarter the company beat on EPS by $0.15 which was followed by a 2.0% drop in the share price the next day.

Here's a look at Fusion Pharmaceuticals's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.40	-0.39	-0.32	-0.56
EPS Actual	-0.25	-0.38	-0.45	-0.55
Revenue Estimate	110K	80K	8.57M	20K
Revenue Actual	2.01M	34K	28K	140K

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Fusion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.